MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 219 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 4.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $401 | -99.8% | 12,061 | +84.8% | 0.04% | +100.0% |
| Q3 2022 | $206,000 | -17.9% | 6,525 | -50.0% | 0.02% | -33.3% |
| Q3 2021 | $251,000 | 0.0% | 13,058 | -11.6% | 0.03% | -25.0% |
| Q3 2020 | $251,000 | -15.2% | 14,776 | -40.6% | 0.04% | -20.0% |
| Q2 2019 | $296,000 | +10.4% | 24,889 | +29.9% | 0.05% | +4.2% |
| Q4 2017 | $268,000 | -28.0% | 19,158 | -26.4% | 0.05% | -20.0% |
| Q3 2017 | $372,000 | +13.4% | 26,021 | +55.0% | 0.06% | -32.6% |
| Q2 2016 | $328,000 | – | 16,789 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |